Japan Anti-Snoring Devices Market Analysis

The Japan Anti-Snoring Devices Market size stood at around xx Bn in 2023 and is projected to reach US $xx Bn by 2033, exhibiting a CAGR of xx% during the forecast period.

The Japan Anti-Snoring Devices Market Executive Summary

Approximately 25% to 50% of adults snore regularly, with about 90 Mn Americans reporting snoring at some point in their lives, and 37 Mn stating they snore regularly. It stems from the inflammation of tissues in the upper airway and causes life-threatening risks such as cardiovascular disease and diabetes. Positional devices, oral appliances, positional aids, and continuous positive airway pressure (CPAP) treatments provide relief by enhancing airflow and avoiding blockage of airways during sleeping.

The market for the anti-snoring device has been growing because of growing awareness of sleep disorders, increasing obesity rates, and the growing elderly population. There is a growing popularity in both invasive and non-invasive treatment options, which include nasal devices, mandibular advancement devices, CPAP machines, and smart wearables. North America is the largest market for injectable drugs followed by Europe and Asia-Pacific, primarily due to increasing accessibility and understanding of healthcare requirements in emerging nations like China and India. Market growth is supported by technology development and new product development.    

Japan Anti-Snoring Devices Market Dynamics

Market Growth Drivers

The market of anti-snoring devices is advancing because of increase in the incidence of snoring problems like obstructive sleep apnea due to obesity and increased life span. Awareness of the relative risks to health and greater comfort and convenience offered by technological advancements in devices are other factors that are driving the demand. On the same note, a rising elderly and overweight population, coupled with rising healthcare expenditure and promotional campaigns on health, is leading to the continued growth of the market. 

Opportunity

The markets with future development opportunities in the anti-snoring devices market are the Asia-Pacific and Latin American markets, which are experiencing enhancements in healthcare systems and a rise in awareness of this condition. Smart features like smart sensors, wireless solutions, and tailored functions will improve device desirability and performance. 

Market Restraints

Some of the challenges affecting the anti-snoring devices market are discomfort among the users, high prices especially where the devices have to be custom made, and questions of inefficiency and lack of adequate scientific evidence. Lack of acceptance related to snoring and competition from related products such as CPAP machines and surgeries also pose as constraints to market growth. Moreover, in areas that are not very exposed to health promotion and awareness campaigns, gaps in knowledge deter demand. 

Competitive Landscape for Anti-Snoring Devices Market in Japan

Key Players

• ResMed Inc.
• Koninklijke Philips N.V.
• SomnoMed
• Fisher & Paykel
• Apnea Sciences
• Tomed

Recent Developments

December 2023, For the first time, the FDA cleared oral devices that treat severe obstructive sleep apnea (OSA). These devices offer an alternative to more common sleep apnea treatments, like continuous positive airway pressure (CPAP) therapy and surgery.

November 2022, Prosomnus announced Nov. 2, 2022, that it received FDA 510(k) clearance for its ProSomnus EVO [PH] sleep and snore device, a precision oral appliance therapy (OAT) device.

February 2021, The FDA authorized marketing of a new prescription device, eXciteOSA, to reduce snoring and mild obstructive sleep apnea. It is the first device used while awake that is intended to improve tongue muscle function, which in time can help prevent the tongue from collapsing backwards and obstructing the airway during sleep.

Mergers and Acquisitions

July 2024, EnsoData announces the acquisition of sleep testing diagnostic technology from Resonea aimed at reducing the cost of systematically addressing sleep apnea across large patient populations. With this acquisition, EnsoData adds acoustic flow and microphone data channels to enable an exciting new way to pre-screen patients for sleep apnea with an FDA-cleared mobile application and extend the diagnostic capabilities of home sleep testing. 

Healthcare Policies and Regulatory Landscape for Anti-Snoring Devices Market in Japan

Policy changes and Reimbursement scenario

Regulatory shifts and favourable healthcare campaigns are fostering the use of anti-snoring devices because sleep disorders, including snoring, and OSA are significant concerns. The deregulation of the approval systems and emphasis placed on minimally invasive procedures are positively influencing the development of new products and market participation. The role of reimbursement scenarios is prominent in the context to insurance coverage in regions involving North America that escalates the adoption. An emerging market is present as existing potential markets can progress over time, and this is also applicable to healthcare systems that can improve the access and reimbursement of anti-snoring treatments.